Literature DB >> 1079987

Platelet indirect radioactive Coombs test. Its utilization for PLA1 grouping.

J P Soulier, C Patereau, J Drouet.   

Abstract

A platelet indirect radioactive Coombs test (PIRC) has been described. The technique for purification and labelling the antiglobulin has been precised. This test allowed the typing of platelets in the PLA system by using an absorbed serum from a mother of a thrombocytopenic child. Six other families of neonatal thrombocytopenias were tested. In three of them, the mothers were found PLA1 negative (PLA2, PLA2). Among a panel of 93 platelets, two (0.022) were found PLA1, negative. This PIRC test has many advantages compared to other tests such as platelet complement fixation, assay for blocking antibodies or antiglobulin consumption: it gives objective and quantitative results and is highly reproducible; anticomplementary serum may be tested.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079987     DOI: 10.1111/j.1423-0410.1975.tb00506.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Laboratory investigation of immune thrombocytopenia.

Authors:  M Warner; J G Kelton
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

2.  [Histocompatibility and thrombocyte transfusion].

Authors:  C Mueller-Eckhardt
Journal:  Blut       Date:  1977-04

Review 3.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

4.  Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation.

Authors:  A Falus; K Merétey; D Bagdy; M Diószegi; U Böhm; E Csák; S Bozsóky
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

5.  Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia.

Authors:  M Derycke; M Dreyfus; J C Ropert; G Tchernia
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.